During biosynthesis of bile acid, carbons 25-26-27 are removed from the cholesterol side-chain. Side-chain oxidation begins either with hydroxylation at the 26-position, in which case the three-carbon fragment is released as propionic acid, or with hydroxylation at the 25-position, in which case the threecarbon fragment is released as acetone. We have previously shown in the rat that the contribution of the 25-hydroxylation pathway can be quantitated in vivo by measuring production of
Introduction
Bile acids are synthesized from cholesterol by a series of ring modifications followed by oxidation and shortening of the side-chain. Oxidation of the side-chain can occur by either of two pathways (Fig. 1) . The first begins with hydroxylation of carbon-26 followed by oxidation to a carboxylic acid and cleavage of the three-carbon fragment as propionic acid (1, 2) .
The second begins with hydroxylation of carbon-25 followed by oxidation to a ketone and cleavage of the three-carbon fragment as acetone (3, 4) . Enzyme systems necessary for both pathways have been identified in rat and human liver (3, 5, 6) . Moreover, intermediates exclusive to each pathway have been identified in bile of normal human subjects (7, 8) .
An issue that has been difficult to resolve is the relative contribution of each of these two pathways to total bile acid synthesis in normal man. Administration to human subjects of radiolabeled intermediates exclusive to either pathway has led to conflicting conclusions. In one study, < 20% ofradiolabeled 5lB-cholestane-3a,7a, 12a,25 tetrol was converted to bile acid (9) . Since normally only trace amounts of this tetrol can be detected in human bile (8) , this finding suggested that 25-hydroxylation was not normally very active in man. In another study, however, administration of radiolabeled trihydroxycoprostanic acid (THCA),' an intermediate exclusive to the 26-hydroxylation, pathway, resulted in production of cholic acid having a specific activity of only 20% of the THCA specific activity (10) . This finding suggested that 80% of bile acid synthesis bypassed THCA, presumably via the 25-hydroxylation pathway.
The relative activity of these two pathways is especially important for understanding the rare sterol storage disease, cerebrotendinous xanthomatosis (CTX). Patients with this disease produce and excrete large amounts of 25-hydroxylated bile alcohols (11) . There are two different hypotheses to explain this finding. The first proposes that the enzymatic defect in CTX is impairment of 26-hydroxylase, forcing side-chain oxidation through an otherwise little used 25-hydroxylation pathway (12) . The second proposes that the 25-hydroxylation pathway is normally dominant, and that the enzymatic defect in CTX is deficient 24-hydroxylation, blocking further oxidation of normally produced 25-hydroxylated intermediates (13) . Quantitating the relative contribution ofthe 25-hydroxylation pathway to normal bile acid synthesis could distinguish between these two alternative hypotheses.
We have recently developed and validated a method for quantitating use of the 25-hydroxylation pathway in the intact rat (14) . Rather (14) . In the present study, we describe adaptation and application of this technique to human subjects.
Methods
Five human volunteers ranging in age from 35 to 68 were studied. Three were male and two were female. All were in apparent good health according to previously published criteria (16 All solvents and chemicals were reagent grade except solvents used for HPLC, which were chromatography grade. All were used without additional purification. The scintillant used for trapping breath CO2 was made from phenethylamine, methanol, and Liquifluor (New England Nuclear, Boston, MA) as previously described (14) .
["4C]26-Cholesterol and ["4C]2-acetone were purchased from New England Nuclear and checked for radiochemical purity as described previously (14) . Neither material contained > 3% radiochemical im- 18-gauge catheter was placed in a forearm vein and a constant infusion of unlabeled acetone at 16.6 umol/min was begun. After 18-24 h of this infusion and with the infusion continuing, breath samples were obtained using the apparatus previously described (15) . Briefly, each subject was placed under a plexiglass hood from which air was drawn through a series of traps containing the scintillation fluid described above to quantitatively collect breath CO2. After duplicate 10-min collections of breath C02, the traps containing scintillant were replaced with traps containing 4.0 ml of an aqueous solution of 2.5 mg/ml 2,4-diritrophenylhydrazine in 2.0 N HCI, 60.0 ml water, and 30 ml toluene. Air was then drawn from the plexiglass box through these traps for two separate 30-min collection periods. For validation studies, a known amount of ["4C]isopropanol was included in the acetone infusion solution.
Isolation of the acetone dinitrophenylhydrazone from breath collections was accomplished by a series of thin-layer chromatographic and high performance chromatographic steps as previously described (14) . Part of each isolate was analyzed for acetone mass by gas-liquid chromatography (14) . Another part ofeach isolate was combusted on a biological oxidizer (Tri-Carb 306; Packard Instrument Co., Downers Grove, IL) for subsequent liquid scintillation counting as previously described (14 The final value for radioactivity was divided by acetone mass to calculate specific activity of breath acetone. This permitted calculation of the production rate of ['4C]acetone by the equation P = (I) (SA), where P is the ['4C]acetone production rate; I, the infusion rate of unlabeled acetone; and SA, the specific activity of breath acetone. (14, 19, 20) , these data indicate that our technique measured ["C]acetone production in these subjects with reasonable accuracy. total bile acid synthesis was < 5% in these five subjects.
Results

Discussion
The methods of the present study have been extensively explained and discussed in a previous publication (14) . To briefly summarize, the method is unusual because it quantitates activity ofa metabolic pathway in vivo by radiolabeling the original substrate, cholesterol, and monitoring generation of a unique radiolabeled byproduct of that pathway, acetone. The usual way of studying metabolic pathways in vivo is to administer a Production of ['4C ]acetone in the present study was calculated as the product of the infusion rate of unlabeled acetone and the breath acetone specific activity (see Methods). The prolonged constant infusion of unlabeled acetone serves two critical functions. First, in the fed state, endogenous acetone production is negligible compared with the infusion rate used in the present study (21) . The infusion rate thus provides a reasonable estimate of total acetone input into the system. Second, this input of unlabeled acetone floods the liver, helping to assure that ["4C]acetone produced in the liver is not rapidly metabolized before reaching the periphery, where it can be measured. Indeed, the major biological prerequisite for validity of this method is that ['4C]acetone produced in the liver cell must thoroughly mix with the infused acetone so that the measured specific activity is representative. To show that this prerequisite was satisfied, we measured production of
which is catabolized almost exclusively to acetone (14, 19, 20) .
In these studies (Table I) , measured production of['4Clacetone was nearly identical to the infusion rate of ['4C]isopropanol.
These data provide strong evidence that the measured specific activity of breath acetone was representative of that in the liver, and that the method overall provides an accurate estimate of ['4C]acetone production in man. We have also reported similarly close agreement between measured ['4C]-acetone production and input of ['4C]isopropanol in the rat ( 14) .
In five human subjects given ['4C]26-cholesterol, we found that production of ['4Cjacetone averaged < 5% of total production of 14C02. This finding indicates very little use of the 25-hydroxylation pathway for bile acid synthesis in man and is fully consistent with nearly identical findings by the same method in the rat (14) . Two earlier independent observations in vivo also suggested that the 25-hydroxylation pathway played at most a minor role in normal bile acid synthesis. First was the incomplete (< 20%) conversion of 5f3-cholestane3a,7a, 12a,25 tetrol to cholic acid in man (9 The rare sterol storage disease, CTX, is characterized in part by production and excretion of large amounts of 25-hydroxylated bile alcohols (11) . Two separate hypotheses have been advanced to explain this finding. The first is that CTX patients have impaired 26-hydroxylase activity, which results in accumulation of 5g3-cholestane-3a,7a, 12a triol and shunting of this intermediate through an otherwise inactive 25-hydroxylase pathway (12) . The second supposes that the 25-hydroxylation pathway is normally dominant and that impaired 24-hydroxylation of 25-hydroxylated intermediates results in their excretion rather than their further transformation to bile acid (13) . In vitro studies have failed to distinguish between these two possibilities because activities ofboth the 24-and the 26-hydroxylase have been reported to be low in CTX patients (12, 13) . The present study, by demonstrating normal dominance of the 26-hydroxylation pathway, eliminates reduced 24-hydroxylation as an explanation for the production of large amounts of 25-hydroxylated bile alcohols in CTX. This is not to say that 24-hydroxylation is not impaired in CTX patients. Indeed, impaired activity of this enzyme remains one possible reason that so little ofthe 25-hydroxy bile alcohols produced in CTX is further oxidized to bile acid.
